ACTAVALON
Actavalon is an oncology company which focus on preventing cancer pathways.
ACTAVALON
Social Links:
Industry:
Biotechnology Health Care Life Science Oncology
Founded:
2013-01-01
Address:
Corona Del Mar, California, United States
Country:
United States
Website Url:
http://www.actavalon.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Amazon SSL By Default ReCAPTCHA ReCAPTCHA V2 GoDaddy DNS AWS Global Accelerator OpenResty GoDaddy SSL
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Mary Crowley Cancer Research Centers
Mary Crowley Cancer Research Centers is a research organisation which is showing concerned service on cancer.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Trishula Therapeutics
Trishula Therapeutics is a biotechnology company that focus on developing cancer medicines.
Venquis Therapeutics
Venquis Therapeutics is a biotechnology company that focuses on chemically targeted protein degradation.
Vincerx Pharma
Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Walden Biosciences
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Current Employees Featured
Founder
Official Site Inspections
http://www.actavalon.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Actavalon"
Actavalon - Crunchbase Company Profile & Funding
Organization. Actavalon . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Actavalon is an oncology company which focus on …See details»
www.actavalon.com
Actavalon is a company that announces appointments of Dr. John Hood to its Board of Directors.See details»
Actavalon Company Profile | Management and Employees List
Actavalon Profile and History Actavalon is an oncology-focused company targeting two fundamental cancer pathways - the p53 tumor suppressor pathway and the Aryl Hydrocarbon …See details»
Actavalon Inc.: Contact Details and Business Profile
Actavalon is an oncology-focused company targeting two fundamental cancer pathways - the p53 tumor suppressor pathway and the Aryl Hydrocarbon Receptor (AhR) pathway. Actavalon's …See details»
Actavalon Company Profile - Office Locations, Competitors ... - Craft
Actavalon is an oncology-focused company targeting the p53 tumor suppressor pathway and the aryl hydrocarbon receptor (AhR) pathway. p53 is a tumor suppressor protein that controls cell …See details»
Actavalon Company Profile 2024: Valuation, Funding & Investors
Actavalon General Information Description. Developer of a broad-spectrum drug designed to treat cancer. The company focuses on the development of a single, broad-spectrum, drug with the …See details»
Actavalon - Overview, News & Similar companies | ZoomInfo.com
Actavalon's small molecules are capable of stabilizing the active conformation of mutant p53 prote ins, thereby restoring tumor suppression activity and preventing oncogenic gain-of-function …See details»
Actavalon - Contacts, Employees, Board Members, Advisors
Organization. Actavalon . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. Actavalon has 3 current …See details»
Actavalon - Crunchbase
Actavalon is an oncology company which focus on preventing cancer pathways.See details»
Actavalon, Inc. - VentureRadar
Actavalon is developing small molecule therapeutics capable of restoring p53 tumor suppression activity lost in human cancer cells. ... Find out more about Actavalon, Inc., Oncology.See details»
Actavalon - Products, Competitors, Financials, Employees, …
Actavalon is developing a small molecule drug that fits into a pocket of a malfunctioning p53 protein—a pocket first identified by Amaro’s team. Actavalon’s research is still preclinical, but if …See details»
Actavalon CEO and Key Executive Team | Craft.co
Actavalon's Chairman and President is Michael S. Egan. Other executives include Elena Dneprovskaia, Chief Scientific Officer. See the full leadership team at Craft.See details»
John Hood - CEO at Actavalon - The Org
John Hood is the current CEO of Actavalon and was previously the CEO and founder of Impact Biomedicines, Inc. John has also co-founded Samumed, a biotechnology company, and …See details»
Actavalon Announces Appointments of Dr. John Hood to Its Board …
SAN DIEGO, Aug. 14, 2018 /PRNewswire/ -- Actavalon, Inc., a preclinical-stage biotechnology company focused on developing small molecules in the field of oncology, today announced it …See details»
Actavalon - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Actavalon is an oncology company which focus on preventing cancer pathways.See details»
Actavalon Announces Appointments of Dr. John Hood to Its
SAN DIEGO, Aug. 14, 2018 /PRNewswire/ -- Actavalon, Inc, a preclinical-stage biotechnology company focused on developing small molecules in the field of oncology, today announced it …See details»
Robin Farmanfarmaian - Forbes Business Development Council
May 31, 2017 Robin Farmanfarmaian is VP of Actavalon and a speaker, author, entrepreneur and angel investor. SOCIAL. ... Turn Your Life Into An Efficient Organization. Your time is …See details»
Research programme: p53 modulators - Actavalon - AdisInsight
Sep 28, 2022 Actavalon is developing small molecules modulating p53 for the treatment of cancer. These molecules are capable of stablilizing the active confirmation of p53 ... If your …See details»
Selective aryl hydrocarbon receptor modulators (Actavalon)
Abstract The human aryl hydrocarbon receptor (AhR), a ligand‐dependent transcription factor, plays a pivotal role in a diverse array of pathways in biological and pathophysiological events. …See details»
Research programme: selective aryl hydrocarbon receptor …
Actavalon is developing a series of highly potent small molecules againts selective aryl hydrocarbon receptor (SAhR) with either agonist, partial agonist or Research programme: …See details»